Company · CIK 0001070336 · SIC 2834 — Pharmaceutical Preparations
ACHILLION PHARMACEUTICALS INC · ACHN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2018 MForm 4 → | Dec 18, 4:24 pm EST | David ScheerDirector | 20,000 | $1.05 | $21,000 | 20,000 | — | plan? |
| Dec 14, 2018 MForm 4 → | Dec 18, 4:22 pm EST | Robert L Van NostrandDirector | 20,000 | $1.05 | $21,000 | 20,000 | — | plan? |
| Jun 6, 2018 MForm 4 → | Jun 8, 4:15 pm EDT | Jason S FishermanDirector | 20,000 | $1.05 | $21,000 | 70,000 | — | plan? |
| May 31, 2018 JForm 4 → | Jun 4, 4:20 pm EDT | Nicole VitulloDirector | 30,000 | — | — | 36,431 | — | plan? |
| Nov 20, 2017 SForm 4 → | Nov 22, 11:44 am EST | JOHNSON & JOHNSON +110% Owner | 18,367,346 | $2.75 | $50,510,202 | 0 | −100% | plan? |
| Aug 10, 2017 FMForm 4 → | Aug 14, 4:47 pm EDT | Nicole VitulloDirector | 4,538,925 | $3.85 | $17,492,061 | 25,159 | — | plan? |
| Jun 28, 2017 WForm 4 → | Jun 30, 4:28 pm EDT | Jason S FishermanDirector | 1,500 | — | — | 1,500 | — | plan? |
| Dec 22, 2016 PForm 4 → | Dec 23, 10:09 am EST | Jason S FishermanDirector | 10,000 | $3.96 | $39,600 | 50,000 | +25.0% | plan? |
| Dec 5, 2016 PForm 4 → | Dec 5, 5:16 pm EST | Mary Kay FentonChief Financial Officer | 2,500 | $4.11 | $10,275 | 2,500 | — | plan? |
| Dec 2, 2016 PForm 4 → | Dec 5, 5:18 pm EST | Joseph TruittChief Commercial Officer | 3,500 | $4.06 | $14,210 | 3,500 | — | plan? |
| Dec 2, 2016 PForm 4 → | Dec 5, 5:17 pm EST | Martha E ManningEVP, General Counsel | 2,500 | $4.09 | $10,225 | 2,500 | — | plan? |
| Dec 2, 2016 PForm 4 → | Dec 5, 5:16 pm EST | Milind DeshpandeChief Executive Officer, Director | 2,500 | $4.06 | $10,150 | 2,500 | — | plan? |
| Dec 2, 2016 PForm 4 → | Dec 5, 5:15 pm EST | Joel C BarrishChief Scientific Officer | 2,500 | $4.06 | $10,150 | 2,500 | — | plan? |
| Dec 30, 2015 SForm 4 → | Dec 30, 4:26 pm EST | David ApelianChief Medical Officer | 10,000 | $10.50 | $105,000 | 0 | −100% | plan? |
| Dec 30, 2015 MForm 4 → | Dec 30, 4:26 pm EST | David ApelianChief Medical Officer | 10,000 | $3.02 | $30,200 | 10,000 | — | plan? |
| Dec 28, 2015 SForm 4 → | Dec 30, 4:25 pm EST | Mary Kay FentonChief Financial Officer | 43,500 | $10.08 | $438,480 | 0 | −100% | plan? |
| Dec 28, 2015 MForm 4 → | Dec 30, 4:25 pm EST | Mary Kay FentonChief Financial Officer | 43,500 | $1.05 | $45,675 | 43,500 | — | plan? |
| Nov 9, 2015 SForm 4 → | Nov 12, 4:54 pm EST | Nicole VitulloDirector | 550,000 | $10.17 | $5,595,711 | 17,179 | −97.0% | plan? late |
| Sep 25, 2015 SForm 4 → | Sep 29, 5:21 pm EDT | Nicole VitulloDirector | 9,310 | $8.22 | $76,528 | 21,249 | −30.5% | plan? |
| Aug 18, 2015 JForm 4 → | Aug 18, 6:07 pm EDT | Nicole VitulloDirector | 514,952 | — | — | 31,431 | — | plan? |
| Aug 14, 2015 SForm 4 → | Aug 18, 6:07 pm EDT | Nicole VitulloDirector | 37,843 | $7.51 | $284,201 | 21,318 | −64.0% | plan? |
| May 21, 2015 JForm 4 → | May 22, 5:11 pm EDT | Nicole VitulloDirector | 1,922,630 | — | — | 483,521 | — | plan? |
| Jan 23, 2015 SForm 4 → | Jan 23, 5:15 pm EST | Mary Kay FentonEVP and CFO | 13,125 | $16.00 | $210,000 | 0 | −100% | plan? |
| Jan 23, 2015 MForm 4 → | Jan 23, 5:15 pm EST | Mary Kay FentonEVP and CFO | 13,125 | $4.00 | $52,500 | 13,125 | — | plan? |
| Jan 21, 2015 SForm 4 → | Jan 23, 5:15 pm EST | Milind DeshpandePresident and CEO, Director | 100,000 | $15.00 | $1,500,000 | 0 | −100% | plan? |
| Jan 21, 2015 MForm 4 → | Jan 23, 5:15 pm EST | Milind DeshpandePresident and CEO, Director | 100,000 | $3.02 | $302,000 | 100,000 | — | plan? |
| Sep 27, 2013 PForm 4 → | Jan 20, 2015, 6:10 pm EST | RA CAPITAL MANAGEMENT, LLC +2Other | 2,152,000 | $3.64 | $7,832,000 | 4,816,562 | +80.8% | plan? late |
| Sep 16, 2013 SForm 4 → | Jan 20, 2015, 6:10 pm EST | RA CAPITAL MANAGEMENT, LLC +2Other | 548,945 | $7.37 | $4,045,632 | 5,280,762 | −9.42% | plan? late |
| Jul 19, 2013 SForm 4 → | Jan 20, 2015, 6:09 pm EST | RA CAPITAL MANAGEMENT, LLC +2Other | 200,080 | $7.19 | $1,438,088 | 4,848,760 | −3.96% | plan? late |
| Jul 17, 2013 PForm 4 → | Jan 20, 2015, 6:09 pm EST | RA CAPITAL MANAGEMENT, LLC +2Other | 698,336 | $6.74 | $4,709,518 | 4,856,521 | +16.8% | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2019 AForm 4 → | Feb 11, 6:25 pm EST | Brian Di DonatoChief Financial Officer | 500,000 | — | — | 500,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:55 pm EST | Frank VerwielDirector | 42,000 | — | — | 42,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:55 pm EST | Robert L Van NostrandDirector | 42,000 | — | — | 42,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:54 pm EST | David ScheerDirector | 42,000 | — | — | 42,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:53 pm EST | Michael D KishbauchDirector | 42,000 | — | — | 42,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:52 pm EST | Kurt GravesDirector | 42,000 | — | — | 42,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:52 pm EST | Jason S FishermanDirector | 42,000 | — | — | 42,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:51 pm EST | Steven ZelenkofskeChief Medical Officer | 200,000 | — | — | 200,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:50 pm EST | Joseph TruittChief Executive Officer, Director | 1,097,000 | — | — | 1,097,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:49 pm EST | Martha E ManningGeneral Counsel | 150,000 | — | — | 150,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:49 pm EST | Keri LantzSee Remarks | 100,000 | — | — | 100,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:48 pm EST | Anthony S GibneyChief Business Officer | 200,000 | — | — | 200,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:47 pm EST | Paul E FirutaChief Operating Officer | 200,000 | — | — | 200,000 | — | |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:30 pm EST | Nicole VitulloDirector | 42,000 | — | — | 42,000 | — | |
| Dec 14, 2018 MForm 4 → | Dec 18, 4:24 pm EST | David ScheerDirector | 20,000 | — | — | 0 | — | |
| Dec 14, 2018 MForm 4 → | Dec 18, 4:22 pm EST | Robert L Van NostrandDirector | 20,000 | — | — | 0 | — | |
| Sep 11, 2018 AForm 4 → | Sep 12, 5:57 pm EDT | Paul E FirutaChief Operating Officer | 400,000 | — | — | 400,000 | — | |
| Aug 20, 2018 AForm 4 → | Aug 21, 6:25 pm EDT | Steven ZelenkofskeChief Medical Officer | 500,000 | — | — | 500,000 | — | |
| Aug 15, 2018 AForm 4 → | Aug 16, 5:34 pm EDT | Anthony S GibneyChief Business Officer | 500,000 | — | — | 500,000 | — | |
| Jun 6, 2018 MForm 4 → | Jun 8, 4:15 pm EDT | Jason S FishermanDirector | 20,000 | — | — | 0 | — | |
| May 1, 2018 AForm 4 → | May 3, 4:59 pm EDT | Joseph TruittChief Executive Officer, Director | 632,000 | — | — | 632,000 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 5:27 pm EST | Milind DeshpandeChief Executive Officer, Director | 640,000 | — | — | 640,000 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 5:26 pm EST | Mary Kay FentonChief Financial Officer | 250,000 | — | — | 250,000 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 5:21 pm EST | Martha E ManningGeneral Counsel | 215,000 | — | — | 215,000 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 5:21 pm EST | Joseph TruittChief Commercial Officer | 419,000 | — | — | 419,000 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 5:20 pm EST | Jason S FishermanDirector | 30,000 | — | — | 30,000 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 5:19 pm EST | Gary E FrashierDirector | 30,000 | — | — | 30,000 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 5:18 pm EST | Kurt GravesDirector | 30,000 | — | — | 30,000 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 5:17 pm EST | Michael D KishbauchDirector | 30,000 | — | — | 30,000 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 5:14 pm EST | David ScheerDirector | 30,000 | — | — | 30,000 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 5:13 pm EST | Robert L Van NostrandDirector | 30,000 | — | — | 30,000 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 5:13 pm EST | Frank VerwielDirector | 30,000 | — | — | 30,000 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 4:32 pm EST | Nicole VitulloDirector | 30,000 | — | — | 30,000 | — | |
| Aug 10, 2017 MForm 4 → | Aug 14, 4:47 pm EDT | Nicole VitulloDirector | 2,811,245 | — | — | 0 | — | |
| Jan 19, 2017 AForm 4 → | Jan 19, 5:36 pm EST | Nicole VitulloDirector | 30,000 | — | — | 30,000 | — | |
| Jan 19, 2017 AForm 4 → | Jan 19, 5:28 pm EST | Frank VerwielDirector | 30,000 | — | — | 30,000 | — | |
| Jan 19, 2017 AForm 4 → | Jan 19, 5:28 pm EST | Robert L Van NostrandDirector | 30,000 | — | — | 30,000 | — | |
| Jan 19, 2017 AForm 4 → | Jan 19, 5:27 pm EST | David ScheerDirector | 30,000 | — | — | 30,000 | — | |
| Jan 19, 2017 AForm 4 → | Jan 19, 5:26 pm EST | Michael D KishbauchDirector | 30,000 | — | — | 30,000 | — | |
| Jan 19, 2017 AForm 4 → | Jan 19, 5:25 pm EST | Kurt GravesDirector | 30,000 | — | — | 30,000 | — | |
| Jan 19, 2017 AForm 4 → | Jan 19, 5:24 pm EST | Gary E FrashierDirector | 30,000 | — | — | 30,000 | — | |
| Jan 19, 2017 AForm 4 → | Jan 19, 5:24 pm EST | Jason S FishermanDirector | 30,000 | — | — | 30,000 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:23 pm EST | Joseph TruittChief Commercial Officer | 185,000 | — | — | 185,000 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:22 pm EST | Martha E ManningEVP, General Counsel | 135,000 | — | — | 135,000 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:22 pm EST | Mary Kay FentonChief Financial Officer | 165,000 | — | — | 165,000 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:21 pm EST | Joel C BarrishChief Scientific Officer | 185,000 | — | — | 185,000 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:21 pm EST | Milind DeshpandeChief Executive Officer, Director | 458,000 | — | — | 458,000 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:20 pm EST | David ApelianChief Medical Officer | 185,000 | — | — | 185,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 3, 4:55 pm EST | Martha E ManningEVP, General Counsel | 110,000 | — | — | 110,000 | — | |
| Jan 25, 2016 AForm 4 → | Jan 27, 5:42 pm EST | Jason S FishermanDirector | 30,000 | — | — | 30,000 | — | |
| Jan 25, 2016 AForm 4 → | Jan 27, 5:41 pm EST | Gary E FrashierDirector | 30,000 | — | — | 30,000 | — | |
| Jan 25, 2016 AForm 4 → | Jan 27, 5:40 pm EST | Kurt GravesDirector | 30,000 | — | — | 30,000 | — | |
| Jan 25, 2016 AForm 4 → | Jan 27, 5:39 pm EST | Michael D KishbauchDirector | 30,000 | — | — | 30,000 | — | |
| Jan 25, 2016 AForm 4 → | Jan 27, 5:39 pm EST | David ScheerDirector | 30,000 | — | — | 30,000 | — | |
| Jan 25, 2016 AForm 4 → | Jan 27, 5:38 pm EST | Robert L Van NostrandDirector | 30,000 | — | — | 30,000 | — | |
| Jan 25, 2016 AForm 4 → | Jan 27, 5:36 pm EST | Frank VerwielDirector | 30,000 | — | — | 30,000 | — | |
| Jan 25, 2016 AForm 4 → | Jan 26, 6:34 pm EST | Nicole VitulloDirector | 30,000 | — | — | 30,000 | — | |
| Jan 20, 2016 AForm 4 → | Jan 22, 4:12 pm EST | Joseph TruittChief Commercial Officer | 142,000 | — | — | 142,000 | — | |
| Jan 20, 2016 AForm 4 → | Jan 22, 4:11 pm EST | Joel C BarrishChief Scientific Officer | 20,000 | — | — | 20,000 | — | |
| Jan 20, 2016 AForm 4 → | Jan 22, 4:10 pm EST | David ApelianChief Medical Officer | 118,000 | — | — | 118,000 | — | |
| Jan 20, 2016 AForm 4 → | Jan 22, 4:09 pm EST | Mary Kay FentonChief Financial Officer | 118,000 | — | — | 118,000 | — | |
| Jan 20, 2016 AForm 4 → | Jan 22, 4:08 pm EST | Milind DeshpandeChief Executive Officer | 400,000 | — | — | 400,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 5, 5:57 pm EST | Joel C BarrishChief Scientific Officer | 250,000 | — | — | 250,000 | — | |
| Dec 30, 2015 MForm 4 → | Dec 30, 4:26 pm EST | David ApelianChief Medical Officer | 10,000 | — | — | 290,000 | — | |
| Dec 28, 2015 MForm 4 → | Dec 30, 4:25 pm EST | Mary Kay FentonChief Financial Officer | 43,500 | — | — | 0 | — | |
| Dec 14, 2015 AForm 4 → | Dec 16, 4:45 pm EST | Frank VerwielDirector | 30,000 | — | — | 30,000 | — | |
| Jan 23, 2015 MForm 4 → | Jan 23, 5:15 pm EST | Mary Kay FentonEVP and CFO | 13,125 | — | — | 0 | — | |
| Jan 21, 2015 MForm 4 → | Jan 23, 5:15 pm EST | Milind DeshpandePresident and CEO, Director | 100,000 | — | — | 300,000 | — | |
| Jul 15, 2013 PSForm 4 → | Jan 20, 2015, 6:09 pm EST | RA CAPITAL MANAGEMENT, LLC +2Other | 23,200 | $0.99 | $22,969 | 7,760 | — | late |